Our Company

Phil Gioia

President

Phil Gioia is President of Nordic Pharma, Inc. He is a highly experienced, passionate commercial leader with over 30 years of generic and branded pharmaceutical experience. He worked previously as Senior VP of Sales and Marketing for Generics with Barr Pharmaceuticals and was part of the team that built the Women’s Health proprietary business unit until its acquisition by Teva. Phil then led the NA Pharmaceutical Business followed by Global Head of Diversified Products and Business Development at Bausch & Lomb until its acquisition by Valeant.

Phil has extensive knowledge and demonstrated successes of business licensing, acquisitions, integrations and exits. He is also the co-founder of Vinci Pharmaceuticals, Inc., a specialty ophthalmic pharmaceutical company and a board advisor to several ophthalmology companies. Phil holds a BS degree from Montclair State University (Marketing) and an MBA from Sacred Heart University.

Tatyana Kosheleva, CPA, MBA

VP Treasurer & CFO

Tatyana is a global finance leader with 25 years of experience from start-ups to Fortune 500 companies in the life sciences and technology industries. Tatyana joined Nordic Pharma in February 2016 as Vice President, Finance and Chief Financial Officer and is responsible for all aspects of the firm’s financial operations. Prior to joining Nordic Pharma, Tatyana was a Country Finance Head at Ferring Pharmaceuticals, a multinational biopharma company, in a growth market in Eastern Europe. Before entering the life sciences industry, Tatyana served as Group CFO at a global software solution arm of DST Systems, a publicly listed technology company (acquired by SS&C), and was based in London, UK. She spent her early career at IBM in Canada and the U.S.

Tatyana is passionate about innovation in health care and serves on the Board of DIA (www.DIAglobal.org), an international multidisciplinary association of life sciences professionals that fosters innovation for improved health and well-being worldwide.

Tatyana is a licensed CPA and holds an MBA degree from Thunderbird School of Global Management, a part of the Arizona State University.

Marina Volin, Esq.

VP, General Counsel & Corporate Secretary

Marina joined Nordic Pharma in May 2020 as Vice President, General Counsel & Corporate Secretary. She oversees all legal matters for the company including contractual agreements, corporate governance, intellectual property, compliance matters and due diligence for business development opportunities.

With more than 20 years of experience representing pharmaceutical companies, Marina came to Nordic Pharma from Kintai Therapeutics of Cambridge, MA where she served as Vice President, Head of Legal and Intellectual Property. Prior to that, she served as Intellectual Property and Corporate Attorney for Windtree Therapeutics, Inc. (formerly Discovery Labs) of Warrington, PA. Marina began her legal career with the law firm Caesar Rivise, PC of Philadelphia, PA. Prior to studying law, Marina served as Scientific Assistant at the Fox Chase Cancer Center, Philadelphia, PA.

Marina earned her Juris Doctorate degree from the Temple University School of Law in Philadelphia and Master of Science and Bachelor of Science degrees in Chemical Engineering from the Gubkin Russian University of Oil and Gas in Moscow. She is a member of the New Jersey and Pennsylvania Bar Associations.

Thomas Sammler

VP, Commercial Operation

As Vice President, Commercial Operation, Tom is responsible for the strategy and tactical execution of the Nordic Pharma Generic product portfolio as well as providing operational leadership and guidance to the Supply Chain team. He leads the identification and pursuit of profitable sales growth at the national, regional, and local levels, across Retail, Specialty, and Institutional Pharmacy. He carries out growth initiatives, such as business development activities, ensuring strong, sustained P&L performance for the company.

Before joining Nordic Pharma in September 2015, Tom was Director, Sales Operations for Impax Laboratories. In that position, he managed sales operations during the company’s integration with the Tower Holding companies. Previously, Tom held various marketing and financial positions at CorePharma, Sandoz, Endo Pharmaceuticals, and DuPont/DuPont Merck. He has experience driving revenues for both generic and branded pharmaceutical products and leading a diverse range of commercial operations, from sales teams and product marketing to supply chain logistics and strategic planning.

Tom graduated with a B.S. in Accounting from Widener University and earned his MBA in Pharmaceutical Marketing from Saint Joseph’s University.

Nancy Fulginiti

VP, Quality

Nancy joined Nordic Pharma in August 2022 as Vice President, Quality. She oversees quality assurance and regulatory compliance. She has more than 25 years of experience with quality in the pharmaceutical industry. Nancy came to Nordic Pharma from CRISPR Therapeutics where she served as Vice President, Quality. Prior to that, she served as Audit Head for Novartis and Executive Director Quality for Sandoz.

Nancy holds a B.S. in Medical Technology from Thomas Jefferson University and an M.S. in Clinical Chemistry from West Chester University.